CAROLE LAHANA: Open Payments
NPI 1023520418 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$667 in 16 payments from 10 companies in 2025. Trend: 2023 $304 · 2024 $224 · 2025 $667
Food & beverage: $582Education: $85
| Company | Payments | Amount |
|---|---|---|
| IMMUNITYBIO, INC. | 3 | $323 |
| Janssen Biotech, Inc. | 2 | $108 |
| Sumitomo Pharma America, Inc. | 3 | $56 |
| PFIZER INC. | 2 | $36 |
| Boston Scientific Corporation | 1 | $32 |
| Dendreon Pharmaceuticals LLC | 1 | $27 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $24 |
| Teleflex LLC | 1 | $23 |
| COLOPLAST CORP | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
Products named: ANKTIVA, ERLEADA, GEMTESA, XTANDI, AdVance XP, PROVENGE, PYLARIFY, DEKNATEL.
Industry payments across FL — which companies pay providers there.
